David J Yvars Group Takes $1.12 Million Position in Doximity, Inc. (NASDAQ:DOCS)

David J Yvars Group acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCS) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 20,966 shares of the company’s stock, valued at approximately $1,119,000. Doximity accounts for about 0.7% of David J Yvars Group’s portfolio, making the stock its 25th largest holding.

Several other institutional investors have also made changes to their positions in DOCS. FMR LLC lifted its holdings in shares of Doximity by 30.5% during the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after acquiring an additional 1,598,602 shares during the period. Clearbridge Investments LLC lifted its holdings in Doximity by 7.1% during the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock valued at $163,709,000 after purchasing an additional 387,200 shares during the last quarter. State Street Corp boosted its position in Doximity by 2.5% in the third quarter. State Street Corp now owns 3,693,982 shares of the company’s stock valued at $160,947,000 after buying an additional 88,922 shares in the last quarter. Geode Capital Management LLC grew its stake in Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after buying an additional 472,565 shares during the last quarter. Finally, Renaissance Technologies LLC increased its holdings in shares of Doximity by 23.1% during the second quarter. Renaissance Technologies LLC now owns 1,603,202 shares of the company’s stock worth $44,842,000 after buying an additional 301,100 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Price Performance

Shares of DOCS stock opened at $49.50 on Tuesday. The stock has a market cap of $9.24 billion, a PE ratio of 56.90, a price-to-earnings-growth ratio of 4.13 and a beta of 1.38. The stock has a 50-day moving average of $53.23 and a 200-day moving average of $41.93. Doximity, Inc. has a one year low of $22.96 and a one year high of $61.75.

Analysts Set New Price Targets

A number of equities research analysts recently commented on DOCS shares. Bank of America increased their price target on Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Stephens began coverage on Doximity in a report on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price target for the company. Robert W. Baird increased their price objective on shares of Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a report on Tuesday, September 17th. Wells Fargo & Company boosted their target price on shares of Doximity from $41.00 to $43.00 and gave the stock an “equal weight” rating in a research note on Monday. Finally, The Goldman Sachs Group assumed coverage on shares of Doximity in a research note on Friday, November 15th. They set a “neutral” rating and a $58.00 price target on the stock. Thirteen analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $53.12.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.